Nanotechnology - Nanomedicine

Arrowhead Reports Fiscal 2010 Fourth Quarter and Year-End Financial Results

Published in Health Business Week, January 7th, 2011

2011 JAN 7 -- Arrowhead Research Corporation (NASDAQ: ARWR) announced financial results for its fiscal 2010 fourth quarter and year ended September 30, 2010.

"Fiscal 2010 was a pivotal year for Arrowhead based on key technology and corporate advancements that reinforce the strength of our business model," said Dr. Christopher Anzalone, Arrowhead's CEO. "Having accomplished the vast majority of our key goals outlined for shareholders earlier this year, we are increasing our ability to operate as a focused nanomedicine company with a strong technology base that address large market opportunities. Some of our most recent achievements include attaining...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2011-01-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry